# Bioavailability and Bioequivalence of Ezetimibe Tablets in Healthy Subjects

> **NCT05681247** · PHASE1 · COMPLETED · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 59 (actual)

## Conditions studied

- Hyperlipidemias

## Interventions

- **DRUG:** ezetimibe tablet
- **DRUG:** ezetimibe tablet(Ezetrol ®)

## Key facts

- **NCT ID:** NCT05681247
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-17
- **Primary completion:** 2018-01-29
- **Final completion:** 2018-03-07
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2023-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05681247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05681247, "Bioavailability and Bioequivalence of Ezetimibe Tablets in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05681247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*